Baseline SUV and early response, but not MTV, are associated with outcome in relapsed/refractory Hodgkin lymphoma patients treated with nivolumab in the CHECKMATE 205 trial Meeting Abstract
| Authors: | Barrington, S. F.; Fischer, B. M.; Kirkwood, A. A.; Grootendorst, D.; Akyol, A.; Ansell, S. M.; Armand, P.; Schwartz, L. H. |
| Abstract Title: | Baseline SUV and early response, but not MTV, are associated with outcome in relapsed/refractory Hodgkin lymphoma patients treated with nivolumab in the CHECKMATE 205 trial |
| Meeting Title: | 17th International Conference on Malignant Lymphoma (ICML) |
| Journal Title: | Hematological Oncology |
| Volume: | 41 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Jun 13-17 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2023-06-01 |
| Start Page: | 92 |
| End Page: | 93 |
| Language: | English |
| DOI: | 10.1002/hon.3163_56 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 056 -- Source: Cinahl |
